The VICC.ORG Directory of Doctors, Healthcare Providers & Researchers
Swati Biswas, Ph.D.
Research Assistant Professor
Research Instructor
Researcher
Contact Information:
Vanderbilt, Department of Radiation Oncology
Medical Center North, DD1215
Nashville, TN 37232-0575
615-322-1107
Fax: 615-343-2611
Education
- Ph.D. Jadavpur University, India
- M.S. Kalyani University, India
- B.S. Kalyani Univeristy, India
Publications
- Biswas, S, Nyman, JS, Alvarez, J, Chakrabarti, A, Ayres, A, Sterling, J, Edwards, J, Rana, T, Johnson, R, Perrien, DS, Lonning, S, Shyr, Y, Matrisian, LM, Mundy, GR Anti-transforming growth factor ß antibody treatment rescues bone loss and prevents breast cancer metastasis to bone. PLoS One, 6(11), e27090, 2011.
- Travis, EL, Rachakonda, G, Zhou, X, Korhonen, K, Sekhar, KR, Biswas, S, Freeman, ML NRF2 deficiency reduces life span of mice administered thoracic irradiation. Free Radic Biol Med, 51(6), 1175-83, 2011.
- Edwards, JR, Nyman, JS, Lwin, ST, Moore, MM, Esparza, J, O''Quinn, EC, Hart, AJ, Biswas, S, Patil, CA, Lonning, S, Mahadevan-Jansen, A, Mundy, GR Inhibition of TGF-β signaling by 1D11 antibody treatment increases bone mass and quality in vivo. J Bone Miner Res, 25(11), 2419-26, 2010.
- Ganapathy, V, Ge, R, Grazioli, A, Xie, W, Banach-Petrosky, W, Kang, Y, Lonning, S, McPherson, J, Yingling, JM, Biswas, S, Mundy, GR, Reiss, M Targeting the Transforming Growth Factor-beta pathway inhibits human basal-like breast cancer metastasis. Mol Cancer, 9122, 2010.
- Biswas, S, Trobridge, P, Romero-Gallo, J, Billheimer, D, Myeroff, LL, Willson, JK, Markowitz, SD, Grady, WM Mutational inactivation of TGFBR2 in microsatellite unstable colon cancer arises from the cooperation of genomic instability and the clonal outgrowth of transforming growth factor beta resistant cells. Genes Chromosomes Cancer, 47(2), 95-106, 2008.
- Biswas, S, Guix, M, Rinehart, C, Dugger, TC, Chytil, A, Moses, HL, Freeman, ML, Arteaga, CL Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression. J Clin Invest, 117(5), 1305-13, 2007.
- Biswas, S, Criswell, TL, Wang, SE, Arteaga, CL Inhibition of transforming growth factor-beta signaling in human cancer: targeting a tumor suppressor network as a therapeutic strategy. Clin Cancer Res, 12(14 Pt 1), 4142-6, 2006.
- Shin, I, Edl, J, Biswas, S, Lin, PC, Mernaugh, R, Arteaga, CL Proapoptotic activity of cell-permeable anti-Akt single-chain antibodies. Cancer Res, 65(7), 2815-24, 2005.
- Biswas, S, Chytil, A, Washington, K, Romero-Gallo, J, Gorska, AE, Wirth, PS, Gautam, S, Moses, HL, Grady, WM Transforming growth factor beta receptor type II inactivation promotes the establishment and progression of colon cancer. Cancer Res, 64(14), 4687-92, 2004.
You do not have JavaScript enabled. This site works better with JavaScript turned on.


